Lamifiban trifluoroacetate is a non-peptide glycoprotein IIb/IIIa receptor and platelet aggregation antagonist; it is used in combination with thrombolytic therapy to effectively restore coronary artery patency and shows potential for the treatment of acute coronary syndrome.